Study finds significant barrier to HIV treatment and prevention in southern states
By Sydney Wayand | September 4, 2020Researchers at U.Va. Health have recently uncovered a systemic barrier in the South impacting the access to a critical HIV treatment and prevention drug called PrEP. A frustrating insurance requirement known as prior authorization has been largely deemed the culprit, researchers reveal.
